Cargando…

Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test

Detalles Bibliográficos
Autores principales:	Waterboer, Tim, Brenner, Nicole, Klussmann, Jens P., Brennan, Paul, Wieland, Ulrike, Robbins, Hilary A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701317/ https://www.ncbi.nlm.nih.gov/pubmed/33249381 http://dx.doi.org/10.1016/j.ebiom.2020.103143

Ejemplares similares

Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”
por: Weiland, Thomas, et al.
Publicado: (2020)

DRH1 – a novel blood-based HPV tumour marker
por: Weiland, Thomas, et al.
Publicado: (2020)

Unique Properties of Hepatocarcinogenesis-Resistant DRH Rat Hepatocytes Linked or Not Linked to the Drh1 Locus on Rat Chromosome 1
por: Hashimoto, Norikazu, et al.
Publicado: (2011)

Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis
por: Hibbert, Julia, et al.
Publicado: (2021)

Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank
por: Brenner, Nicole, et al.
Publicado: (2020)

DRH1, a p68-related RNA helicase gene, is required for chromosome breakage in Tetrahymena
por: McDaniel, Stephen L., et al.
Publicado: (2016)

Maternal HPV-antibodies and seroconversion to HPV in children during the first 3 years of life
por: Syrjänen, Stina, et al.
Publicado: (2022)

Mutation of the histidin residue of the DRH motif in vasopressin V2 receptor expression and function
por: Mir Mohammad Sadeghi, H., et al.
Publicado: (2010)

C. elegans Dicer acts with the RIG-I-like helicase DRH-1 and RDE-4 to cleave dsRNA
por: Consalvo, Claudia D., et al.
Publicado: (2023)

HPV16 E6 seropositivity among cancer-free men with oral, anal or genital HPV16 infection
por: Beachler, Daniel C., et al.
Publicado: (2016)

Outcomes of HPV type-specific serostatus do not associate with oral or genital HPV-carriage in non-vaccinated women followed for three years
por: Vuorinen, Salla, et al.
Publicado: (2022)

Reduced T Cell Response in Carcinogen‐sensitive Donryu Rats Compared with Carcinogen‐resistant DRH Rats
por: Mise‐Omata, Setsuko, et al.
Publicado: (1999)

Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action
por: Sharma, Shachi Jenny, et al.
Publicado: (2022)

Insights into the structure and RNA-binding specificity of Caenorhabditis elegans Dicer-related helicase 3 (DRH-3)
por: Li, Kuohan, et al.
Publicado: (2021)

Viral Integration Analysis Reveals Likely Common Clonal Origin of Bilateral HPV16-Positive, p16-Positive Tonsil Tumors
por: Pinatti, Lisa M., et al.
Publicado: (2020)

Integration of HPV6 and Downregulation of AKR1C3 Expression Mark Malignant Transformation in a Patient with Juvenile-Onset Laryngeal Papillomatosis
por: Huebbers, Christian Ulrich, et al.
Publicado: (2013)

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium
por: Kreimer, A R, et al.
Publicado: (2019)

Double-stranded RNA-dependent ATPase DRH-3: INSIGHT INTO ITS ROLE IN RNA SILENCING IN CAENORHABDITIS ELEGANS
por: Matranga, Christian, et al.
Publicado: (2010)

Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology – A proof-of-concept study
por: Busch, Chia-Jung, et al.
Publicado: (2022)

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection
por: Gradissimo, Ana, et al.
Publicado: (2021)

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial
por: Tsang, Sabrina H., et al.
Publicado: (2022)

Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay
por: Galati, Luisa, et al.
Publicado: (2022)

Comprehensive Analysis of HPV16 Integration in OSCC Reveals No Significant Impact of Physical Status on Viral Oncogene and Virally Disrupted Human Gene Expression
por: Olthof, Nadine C., et al.
Publicado: (2014)

Quality of life and associated factors among family caregivers of individuals with psychiatric illness at DRH, South Wollo, Ethiopia, 2020
por: Gelaye, Habtam, et al.
Publicado: (2022)

Effect of a Second Pregnancy on the HPV Serology in Mothers Followed Up in the Finnish Family HPV Study
por: Suominen, Helmi, et al.
Publicado: (2023)

Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium
por: Robbins, Hilary A., et al.
Publicado: (2022)

Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations
por: Rahman, Shams, et al.
Publicado: (2017)

More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population
por: Marais, Dianne J, et al.
Publicado: (2006)

A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein
por: Stolbikov, A.S., et al.
Publicado: (2021)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

Role of HPV16 E1 in cervical carcinogenesis
por: Baedyananda, Fern, et al.
Publicado: (2022)

Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes
por: Fontan, Christian T., et al.
Publicado: (2020)

High Levels of Epstein–Barr Virus Nuclear Antigen-1-Specific Antibodies and Infectious Mononucleosis Act Both Independently and Synergistically to Increase Multiple Sclerosis Risk
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

Comparison of a VLP‐based and GST‐L1‐based multiplex immunoassay to detect vaccine‐induced HPV‐specific antibodies in first‐void urine
por: Pattyn, Jade, et al.
Publicado: (2020)

Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer
por: Ferreiro-Iglesias, Aida, et al.
Publicado: (2021)

Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer
por: Wittekindt, Claus, et al.
Publicado: (2012)

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody
por: Peng, Shiwen, et al.
Publicado: (2021)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands
por: King, Audrey J., et al.
Publicado: (2016)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1b54a2vc76j1setshf0eoch520